| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2004 | US6683062 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 01/27/2004 | US6683060 Chelating zinc with 1-(3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl)pyrimidine -2,4(1h,3h)-dione; ovarian cancer |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6683057 Suppressing g beta gamma signaling; reducing intimal hyper-plasia following vein grafting and restenosis following arterial injury |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683050 Compounds with anti-KS and anti-HIV activity |
| 01/27/2004 | US6683029 Halopyrimidines |
| 01/27/2004 | US6682930 Triplex forming oligonucleotides and their use in anti-HBV |
| 01/27/2004 | US6682761 Water-insoluble drug particle process |
| 01/27/2004 | US6682759 Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| 01/27/2004 | US6682758 Water-insoluble drug delivery system |
| 01/27/2004 | US6682757 Patch units |
| 01/27/2004 | US6682749 Low Residue cosmetic composition |
| 01/27/2004 | US6682747 Process for preparing an oral suspension of a pharmaceutical substance |
| 01/27/2004 | US6682744 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | US6682716 Delivery of aerosols containing small particles through an inhalation route |
| 01/27/2004 | US6682545 System and device for preventing restenosis in body vessels |
| 01/27/2004 | US6682348 Dispensing apparatus and cartridge |
| 01/27/2004 | CA2292920C New spiroimidazolin derivatives, the process for preparing them and the pharmaceutical compositions that contain them |
| 01/27/2004 | CA2281927C Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 01/27/2004 | CA2261095C Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
| 01/27/2004 | CA2254772C Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/27/2004 | CA2214720C Arylsulfonylamino hydroxamic acid derivatives |
| 01/27/2004 | CA2188110C Pesticidal dry powder formulation enriched in azadirachtin upto 88%, an emulsifiable concentrate enriched upto 30% of azadirachtin and a process for preparing such formulation andconcentrate from neem seed/kernel |
| 01/27/2004 | CA2179682C Pharmaceutical, orally applicable composition |
| 01/27/2004 | CA2166089C 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof |
| 01/27/2004 | CA2149872C Diabetes prevention and treatment |
| 01/27/2004 | CA2129043C Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema |
| 01/27/2004 | CA2123739C Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 01/27/2004 | CA2120048C Pharmaceutical composition having analgesic activity |
| 01/27/2004 | CA2115015C Process for the preparation of 6alpha,9alpha-difluorinated steroids and novel intermediates obtained thereby |
| 01/27/2004 | CA2109150C Heat sealable shrink laminate |
| 01/27/2004 | CA2098821C Benzodioxane derivatives |
| 01/27/2004 | CA2092979C Cyclodextrin inclusion complex of paclitaxel, and method for its production and its use |
| 01/27/2004 | CA2081604C Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| 01/27/2004 | CA2069483C Steroid sulphatase inhibitors |
| 01/27/2004 | CA2069200C Crystalline acid addition salts of diastereomerically pure 1-(2,2-dimethylpropionyloxy)-ethyl-3-cephem-4-carboxylate |
| 01/27/2004 | CA2050569C Diphenyl compounds which inhibit arachidonic acid metabolism, and their use in pharmaceutical compositions |
| 01/25/2004 | CA2435526A1 Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 01/25/2004 | CA2429287A1 Stable amorphous calcium pseudomonate and processes for the preparation thereof |
| 01/22/2004 | WO2004008147A2 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | WO2004007772A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression |
| 01/22/2004 | WO2004007770A2 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | WO2004007764A2 Chromosome 3, 5 and 11 genes involved in premature canities |
| 01/22/2004 | WO2004007743A2 Use of cpg nucleic acids in prion-disease |
| 01/22/2004 | WO2004007742A2 Chromosome 6 and 9 genes involved in premature canities |
| 01/22/2004 | WO2004007734A1 Her-2/neu dna vaccine having anti-cancer activity |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007680A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
| 01/22/2004 | WO2004007676A2 Combination therapy for the treatment of neoplasms |
| 01/22/2004 | WO2004007531A2 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | WO2004007522A2 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 01/22/2004 | WO2004007517A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 01/22/2004 | WO2004007516A1 Process for producing glycoside |
| 01/22/2004 | WO2004007515A1 Sulfotransferase inhibitors |
| 01/22/2004 | WO2004007512A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/22/2004 | WO2004007507A1 Process for controlling the hydrate mix of a compound |
| 01/22/2004 | WO2004007505A1 Cephalosporins |
| 01/22/2004 | WO2004007503A1 Therapeutic or preventive agent for nausea/vomiting |
| 01/22/2004 | WO2004007502A1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 01/22/2004 | WO2004007499A1 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007498A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007497A1 Process for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine |
| 01/22/2004 | WO2004007496A1 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides |
| 01/22/2004 | WO2004007494A1 Phenylalanine enamide derivatives |
| 01/22/2004 | WO2004007492A1 Novel macrocycles for the treatment of cancer |
| 01/22/2004 | WO2004007491A1 Azolidinone-vinyl fused-benzene derivatives |
| 01/22/2004 | WO2004007488A2 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007483A1 Novel macrocycles for the treatment of cancer diseases |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007478A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 01/22/2004 | WO2004007477A1 Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 01/22/2004 | WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf) |
| 01/22/2004 | WO2004007472A1 Ccr4 antagonist and medicinal use thereof |
| 01/22/2004 | WO2004007470A1 Novel anthracene derivatives and the use thereof as a medicament |
| 01/22/2004 | WO2004007468A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | WO2004007464A1 Imidazole derivative |
| 01/22/2004 | WO2004007461A1 8-hydroxy quinoline derivatives |
| 01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007456A1 Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007455A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | WO2004007454A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 01/22/2004 | WO2004007453A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 01/22/2004 | WO2004007451A1 Indole-3-sulphur derivatives |
| 01/22/2004 | WO2004007450A1 Novel indoline compound and medicinal use thereof |
| 01/22/2004 | WO2004007444A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/22/2004 | WO2004007441A2 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004007430A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 01/22/2004 | WO2004007429A1 Cinnamide derivatives |
| 01/22/2004 | WO2004007423A1 Novel salt forms of poorly soluble probucol esters and ethers |
| 01/22/2004 | WO2004007417A1 Enzyme inhibitors |
| 01/22/2004 | WO2004007025A1 Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib |
| 01/22/2004 | WO2004006975A1 Stents containing sgc activators |